The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Lack of evidence for a harmful effect of sodium‐glucose co‐transporter 2 ( SGLT2 ) inhibitors on fracture risk among type 2 diabetes patients: a network and cumulative meta‐analysis of randomized controlled trials
Abstract
Aim: To evaluate the comparative effects of sodium‐glucose co‐transporter 2 ( SGLT2 ) inhibitors on risk of bone fracture in patients with type 2 diabetes mellitus ( T2DM ). Methods: PubMed , EMBASE , CENTRAL and ClinicalTrials.gov were systematically searched from inception to 27 J anuary 2016 to identify randomized controlled trials ( RCTs ) reporting the outcome of fracture in patients with T2DM treated with SGLT2 inhibitors. Pairwise and network meta‐analyses, as well as a cumulative meta‐analysis, were performed to calculate odds ratios ( ORs ) and 95% confidence intervals ( CIs ). Results: A total of 38 eligible RCTs (10 canagliflozin, 15 dapagliflozin and 13 empagliflozin) involving 30 384 patients, with follow‐ups ranging from 24 to 160 weeks, were included. The fracture event rates were 1.59% in the SGLT2 inhibitor groups and 1.56% in the control groups. The incidence of fracture events was similar among these three SGLT2 inhibitor groups. Compared with placebo, canagliflozin ( OR 1.15; 95% CI 0.71‐1.88), dapagliflozin ( OR 0.68; 95% CI 0.37‐1.25) and empagliflozin ( OR 0.93; 95% CI 0.74‐1.18) were not significantly associated with an increased risk of fracture. Our cumulative meta‐analysis indicated the robustness of the null findings with regard to SGLT2 inhibitors. Conclusions: Our meta‐analysis based on available RCT data does not support the harmful effect of SGLT2 inhibitors on fractures, although future safety monitoring from RCTs and real‐world data with detailed information on bone health is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269 · cited 1×
“The report of this review was performed according to the checklist of the PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of healthcare interventions.(14)”
MethodGraphical tools for network meta-analysis in STATA
Chaimani, A., Higgins, J. P. T., Mavridis, D., Spyridonos, P., & Salanti, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076654 · Cited by 2,473
Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies
Higgins, J. P. T., Jackson, D., Barrett, J. K., Lu, G., Ades, A. E., & White, I. R. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1044 · Cited by 2,098 · cited 1×
“the assumption of consistency in the entire network, a design-bytreatment interaction model using the chi-squared test was used.(24) In addition, a comparison-adjusted funnel plot was used to assess smallstudy effects within a network of interventions.”
MethodSalanti, G. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1037 · Cited by 1,729
White, I. R., Barrett, J. K., Jackson, D., & Higgins, J. P. T. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.1045 · Cited by 1,114
Much ado about nothing: a comparison of the performance of meta-analytical methods with rare events
Bradburn, M. J., Deeks, J. J., Berlin, J. A., & Russell Localio, A. (2007) · Statistics in Medicine · doi:10.1002/sim.2528 · Cited by 938
Turner, R. M., Davey, J., Clarke, M. J., Thompson, S. G., & Higgins, J. P. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys041 · Cited by 837
Kohan, D. E., Fioretto, P., Tang, W., & List, J. F. (2014) · Kidney International · doi:10.1038/ki.2013.356 · Cited by 652 · cited 1×
“patients with moderate renal impairment received dapagliflozin and experienced more bone fracture events than those observed with placebo over 104 weeks of follow-up.(12) By contrast, fewer fracture”
BackgroundEvaluation of inconsistency in networks of interventions
Veroniki, A. A., Vasiliadis, H. S., Higgins, J. P., & Salanti, G. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dys222 · Cited by 576 · cited 1×
“To check for the presence of inconsistency, a loop inconsistencyspecific approach was introduced to evaluate the difference between direct and indirect estimates for a specific comparison.(23) To check”
MethodChaimani, A., & Salanti, G. (2012) · Research Synthesis Methods · doi:10.1002/jrsm.57 · Cited by 521 · cited 1×
“In addition, a comparison-adjusted funnel plot was used to assess smallstudy effects within a network of interventions.(25)”
Method
Cited by
Lytvyn, Y., Bjornstad, P., Udell, J. A., Lovshin, J. A., & Cherney, D. Z. I. (2017) · Circulation · doi:10.1161/circulationaha.117.030012 · Cited by 459
SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
Tentolouris, A., Vlachakis, P., Tzeravini, E., Eleftheriadou, I., & Tentolouris, N. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16162965 · Cited by 300
Donnan, J. R., Grandy, C. A., Chibrikov, E., Marra, C. A., Aubrey-Bassler, K., Johnston, K., Swab, M., Hache, J., Curnew, D., Nguyen, H., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-022577 · Cited by 222
Contributors to impaired bone health in type 2 diabetes
Sheu, A., Greenfield, J. R., White, C. P., & Center, J. R. (2023) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2022.11.003 · Cited by 69
Landgraf, R., Aberle, J., Birkenfeld, A. L., Gallwitz, B., Kellerer, M., Klein, H., Müller-Wieland, D., Nauck, M. A., Reuter, H.-M., & Siegel, E. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1018-9106 · Cited by 62
“Two metaanalyses also showed no significant increase in fracture rates under therapy with SGLT-2 inhibitors, although the time of oberservation and follow-up were relatively short and the incidence rates for fractures were very low [104, 105].”
Metadata
- Authors
- Tang, H. L., Li, D. D., Zhang, J. J., Hsu, Y. H., Wang, T. S., Zhai, S. D., & Song, Y. Q.
- Venue
- Diabetes, Obesity and Metabolism
- Publisher
- Wiley
- Published
- 2016-08-15
- Volume
- 18
- Issue
- 12
- Pages
- 1199-1206
- ISSN
- 1462-8902 (ISSN-L)
- 1463-1326
- OpenAlex
- W2468733412
- Cited by
- 161
- References
- 11
- FWCI
- 19.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lack of evidence for a harmful effect of sodium‐glucose co‐transporter 2 ( SGLT2 ) inhibitors on fracture risk among type 2 diabetes patients: a network and cumulative meta‐analysis of randomized controlled trials. https://app.cochat.ai/papers/10.1111/dom.12742
- The paper
- Tang, H. L., Li, D. D., Zhang, J. J., Hsu, Y. H., Wang, T. S., Zhai, S. D., & Song, Y. Q. (2016). Lack of evidence for a harmful effect of sodium‐glucose co‐transporter 2 ( SGLT2 ) inhibitors on fracture risk among type 2 diabetes patients: a network and cumulative meta‐analysis of randomized controlled trials. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.12742
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.